Cargando…

Analysis of China's fight against COVID-19 from the perspective of policy tools—policy capacity

Judging from the number of confirmed cases, deaths, cures and the time taken to restore normal social and economic order, China is undoubtedly one of the most successful countries in fighting the COVID-19 pandemic, which highlights strong policy capacity of Chinese government using policy tools to s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Shuicheng, Feng, Shuaiyao, Ning, Xiaoling, Zhou, Yiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531593/ https://www.ncbi.nlm.nih.gov/pubmed/36203691 http://dx.doi.org/10.3389/fpubh.2022.951941

Ejemplares similares

Which Matters More in Fighting COVID-19—Government Policy or Community Participation?
por: Qian, Ying, et al.
Publicado: (2022)

Lessons From Italy's and Sweden's Policies in Fighting COVID-19: The Contribution of Biomedical and Social Competences
por: Farina, Mirko, et al.
Publicado: (2020)

China's Public Health Policies in Response to COVID-19: From an “Authoritarian” Perspective
por: Gao, Jinghua, et al.
Publicado: (2021)

Health policy under the microscope: a micro policy design perspective
por: Capano, Giliberto, et al.
Publicado: (2023)

The Post-COVID-19 Economic Policy Uncertainty and the Effectiveness of Monetary Policy: Evidence From China
por: Song, Yuegang, et al.
Publicado: (2021)

Research on China's Monetary Policy Orientation and Regulation in COVID-19
por: Zhou, Baicheng, et al.
Publicado: (2022)

Policy style, consistency and the effectiveness of the policy mix in China’s fight against COVID-19
por: Mei, Ciqi
Publicado: (2020)

A national fight against COVID‐19: lessons and experiences from China
por: Wang, Lixia, et al.
Publicado: (2020)

Influence of carbon emission trading policy on residents' health in China
por: Guo, Bingnan, et al.
Publicado: (2022)

Global law, policy, and governance for effective prevention and control of COVID-19: A comparative analysis of the law and policy of Pakistan, China, and Russia
por: Bilawal Khaskheli, Muhammad, et al.
Publicado: (2023)

Exploring Extension Agent Capacity and Readiness to Adopt Policy, Systems and Environmental Change Approaches
por: Washburn, Lisa, et al.
Publicado: (2022)

Cyber-infrastructure and epidemic precautionary policy: evidence from China
por: Gao, Qiuming, et al.
Publicado: (2023)

COVID-19's Impact on China's Strategic Emerging Industries: An Observation of Policy Difficulties
por: Li, Dexuan, et al.
Publicado: (2022)

The Rise in Norovirus-Related Acute Gastroenteritis During the Fight Against the COVID-19 Pandemic in Southern China
por: Lu, Ying, et al.
Publicado: (2022)

The evolution of mental health related policies in China: A bibliometric analysis, 1987–2020
por: Li, Haiyan, et al.
Publicado: (2022)

Research, Practice, and Policy Perspectives on Evidence-Based Programing for Older Adults
por: Ory, Marcia G., et al.
Publicado: (2015)

Research on the Dynamic Feedback Mechanism of Fiscal Policy Regulation Under COVID-19: Evidence From China
por: Wang, Shu, et al.
Publicado: (2022)

China's Hainan Free Trade Port: Medical Laws and Policy Reform
por: Qi, Fei, et al.
Publicado: (2021)

Born to Win: Reproductive Health Policy and Urban Education Returns in China
por: Gao, Qing, et al.
Publicado: (2022)

China's “dynamic clearing” epidemic prevention policy: Achievements, challenges, and prospects
por: Wang, Quansheng, et al.
Publicado: (2022)

Evaluation of a medical education policy with compulsory rural service in China
por: Hu, Dan, et al.
Publicado: (2023)

Economic Policy Uncertainty in China and Bitcoin Returns: Evidence From the COVID-19 Period
por: Chen, Tiejun, et al.
Publicado: (2021)

Lexical Features of Economic Legal Policy and News in China Since the COVID-19 Outbreak
por: Liu, Jiaqi
Publicado: (2022)

Does public health policy quality foster state innovation capacity? Evidence from a global panel data
por: Ji, Xiaoyi, et al.
Publicado: (2022)

Speech After Long Silence—An Appraisee-Based Comprehensive Analysis With Retrospective and Future Perspectives on Current ID Policy of Transpersons in China
por: Shi, Jian, et al.
Publicado: (2021)

Monitoring Covid-19 Policy Interventions
por: Giudici, Paolo, et al.
Publicado: (2020)

China's Fight Against COVID-19: What We Have Done and What We Should Do Next?
por: Cheng, Sixiang, et al.
Publicado: (2022)

Real-Time Estimation of R(t) for Supporting Public-Health Policies Against COVID-19
por: Contreras, Sebastián, et al.
Publicado: (2020)

Side-Effects of Public Health Policies Against Covid-19: The Story of an Over-Reaction
por: Lansiaux, Edouard, et al.
Publicado: (2021)

Evolution of anti-malaria policies and measures in P.R. China for achieving and sustaining malaria-free
por: Yin, Jian-Hai, et al.
Publicado: (2023)

Legal Framework and Retirement Policies in Serbia from 1990 to 2016 – Gendered Perspective
por: Milovanovic, Olivera, et al.
Publicado: (2016)

Rarecare: A policy perspective on the burden of rare diseases on caregivers in Latin America
por: Dias, Ariadne Guimarães, et al.
Publicado: (2023)

How the Italian NHS Is Fighting Against the COVID-19 Emergency
por: Boccia, Stefania, et al.
Publicado: (2020)

Dynamic zero COVID policy in the fight against COVID
por: Burki, Talha
Publicado: (2022)

How to promote grass roots medical treatment under China's graded diagnosis and treatment policy? — From the perspective of customer value theory
por: Tao, Wanqiong, et al.
Publicado: (2022)

Policy Implementation Science to Advance Population Health: The Potential for Learning Health Policy Systems
por: Oh, April, et al.
Publicado: (2021)

Impact of the first wave of COVID-19 on Crohn’s disease after the end of “zero-COVID” policy in China
por: Hu, Wen, et al.
Publicado: (2023)

The shift of percent excess mortality from zero-COVID policy to living-with-COVID policy in Singapore, South Korea, Australia, New Zealand and Hong Kong SAR
por: Cao, Xiaohan, et al.
Publicado: (2023)

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study
por: Zhu, Hong, et al.
Publicado: (2022)

Patients' Willingness of First Visit in Primary Medical Institutions and Policy Implications: A National Cross-Sectional Survey in China
por: Li, Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2lmuapvs7me8g1c6h52mi9nem1